Tumor microenvironment-adjusted prognostic implications of the KRAS mutation subtype in patients with stage III colorectal cancer treated with adjuvant FOLFOX.
Sci Rep
; 11(1): 14609, 2021 07 16.
Article
in En
| MEDLINE
| ID: mdl-34272423
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Colorectal Neoplasms
/
Lymphocytes, Tumor-Infiltrating
/
Proto-Oncogene Proteins p21(ras)
/
Tumor Microenvironment
Type of study:
Prognostic_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Sci Rep
Year:
2021
Document type:
Article
Affiliation country:
South Korea
Country of publication:
United kingdom